Oppenheimer & Co’s Evolv Technologies EVLV Stock Holding History

Oppenheimer & Co’s Portfolio EVLV Stock Details EVLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$329K	Sell	54,412 -100	-0.2%	-$585	﹤0.01%	1349
2025 Q4	$390K	Buy	54,512 +3,000	+6%	+$21.3K	0.01%	1169
2025 Q3	$389K	Buy	51,512 +6,350	+14%	+$46.4K	﹤0.01%	1276
2025 Q2	$282K	Sell	45,162 -8,250	-15%	-$38.2K	﹤0.01%	1386
2025 Q1	$167K	Hold	53,412	–	–	﹤0.01%	1478
2024 Q4	$211K	Sell	53,412 -1,000	-2%	-$3.51K	﹤0.01%	1434
2024 Q3	$220K	Buy	54,412 +3,051	+6%	+$10.6K	﹤0.01%	1370
2024 Q2	$131K	Sell	51,361 -1,000	-2%	-$3.31K	﹤0.01%	1373
2024 Q1	$233K	Buy	52,361 +1,500	+3%	+$6.48K	﹤0.01%	1282
2023 Q4	$240K	Buy	50,861 +5,053	+11%	+$21.6K	﹤0.01%	1217
2023 Q3	$223K	Buy	45,808 +11,403	+33%	+$70.2K	﹤0.01%	1235
2023 Q2	$206K	Buy	+34,405	New	+$163K	﹤0.01%	1279

Other funds holding EVLV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SPCM

Stoic Point Capital Management Palo Alto, California $103M AUM

DCI

Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Oppenheimer & Co's EVLV Position: Q1 2026 in Review

Oppenheimer & Co reduced its Evolv Technologies (EVLV) stake by 0.18% in Q1 2026, selling an estimated $585 and leaving 54,412 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #1349.

Oppenheimer & Co first reported a position in EVLV in Q2 2023 and has held it in 12 quarters since. The position peaked at $390K in Q4 2025. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.

Oppenheimer & Co held 54,412 shares of Evolv Technologies worth $329K as of Q1 2026.
Oppenheimer & Co sold 100 Evolv Technologies shares in Q1 2026, an estimated $585.
Evolv Technologies made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1349 holding.
Oppenheimer & Co first reported a position in Evolv Technologies in Q2 2023 and has held it in 12 quarters since.
Oppenheimer & Co's Evolv Technologies position peaked at $390K in Q4 2025.
260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.